Mammalian artificial chromosomes (MACs) represent powerful tools for h
uman gene therapy and animal transgenesis. First-generation linear gen
omic human artificial chromosomes (HACs) and circular chimeric genomic
/viral mouse artificial episomal chromosomes (MAECs) have been develop
ed. HACs have been shuttled from human into mouse embryonal stem cells
and human trans-chromosomic mice have been generated. The potential o
f new genetic cis-elements and epigenetic phenomena for de novo segreg
ation and replication activities on MACs are points for discussion. On
ce the size and delivery constraints of HACs are circumvented, therape
utic applications will be numerous, particularly for recessive syndrom
es involving large genes and multigenic diseases.